Fluticasone Propionate
Mostrando 1-12 de 21 artigos, teses e dissertações.
-
1. Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol,
Resumo Objetivo: São escassos os estudos que avaliaram a relação entre a taxa de adesão à combinação de proprionato de fluticasona/xinafoato de salmeterol e o nível de controle da asma na infância. O presente estudo teve como objetivo avaliar essa relação. Métodos: Estudo prospectivo observacional com 84 participantes, de 5 a 16 anos, todos ele
J. Pediatr. (Rio J.). Publicado em: 2019-02
-
2. DEVELOPMENT AND VALIDATION OF METHODOLOGY FOR THE EVALUATION OF FLUTICASONE BY LIQUID CHROMATOGRAPHY AND CAPILLARY ELECTROPHORESIS / DESENVOLVIMENTO E VALIDAÇÃO DE METODOLOGIA PARA AVALIAÇÃO DE FLUTICASONA POR CROMATOGRAFIA LÍQUIDA E ELETROFORESE CAPILAR
Fluticasone propionate (FP) is a synthetic glucocorticoid with potent anti-inflammatory activity that has been effectively used for the treatment of seasonal and allergic perennial rhinitis, minimizing systemic activity. In the present study, the methods were developed and validaded for assessment of FP in pharmaceutical products. The analysis by reversed-ph
Publicado em: 2009
-
3. Estudo da função das glandulas supra-renais em pacientes asmaticos em uso de beclometasona e fluticasona
Bronchial asthma is widely known as a chronic inflammatory disease of the airways and corticosteroids are the most effective drugs for asthma treatment since they block many of the inflammatory mechanisms of the disease and they have prophylactic action. In the last decades, with the introduction of inhaled corticotherapy, there was a reduction in the period
Publicado em: 2001
-
4. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
This study was designed to compare the efficacy and safety of a new inhaled corticosteroid, fluticasone propionate at a total daily dose of 200 micrograms, with beclomethasone dipropionate 400 micrograms/day in childhood asthma. A total of 398 asthmatic children (aged 4-19 years) were randomised to receive either fluticasone propionate 200 micrograms daily o
-
5. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro.
BACKGROUND--Corticosteroids are widely used in the treatment of many inflammatory conditions but the exact mode of action on neutrophil function is uncertain. Fluticasone propionate is a new topically active synthetic steroid which can be measured in body fluids and which undergoes first pass metabolism. METHODS--The effects of fluticasone propionate on the
-
6. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
BACKGROUND: A study was performed to compare the adrenal suppression caused by inhaled fluticasone propionate and budesonide on a microgram equivalent basis, each given by metered dose inhaler to asthmatic patients. METHODS: Twelve asthmatic patients of mean age 29.9 years, with a forced expiratory volume in one second (FEV1) 92.9% predicted and forced expir
-
7. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
BACKGROUND--Fluticasone propionate is a new inhaled corticosteroid with a 2:1 efficacy ratio compared with beclomethasone dipropionate with regard to lung function and symptom scores, without increased systemic activity. The aim of this study was to investigate whether this was also the case for bronchial hyperresponsiveness, assessed by both a direct (hista
-
8. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
BACKGROUND--High dose inhaled glucocorticosteroids are increasingly used in the management of patients with moderate to severe asthma. Although effective, they may cause systemic side effects. Fluticasone propionate is a topically active inhaled glucocorticosteroid which has few systemic effects at high doses. METHODS--Fluticasone propionate, 1.5 mg per day,
-
9. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate.
Short-term lower leg growth was investigated with twice weekly knemometry measurements in 19 schoolchildren with mild asthma during treatment with daily doses of 200 micrograms fluticasone propionate, 400 micrograms, and 800 micrograms beclomethasone dipropionate from a dry powder inhaler. The design was a randomised, double blind, crossover trial. After a r
-
10. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
Objectives To assess the effect of montelukast versus salmeterol added to inhaled fluticasone propionate on asthma exacerbation in patients whose symptoms are inadequately controlled with fluticasone alone.
BMJ Publishing Group Ltd..
-
11. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study
Objective To explore the efficacy and safety of fluticasone propionate, cream and ointment, applied twice weekly in addition to maintenance treatment with emollients, in reducing the risk of relapse of chronic recurrent atopic dermatitis.
BMJ Publishing Group Ltd..
-
12. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
BACKGROUND: The aim of this study was to compare the systemic bioactivity of inhaled budesonide (B) and fluticasone propionate (F), each given by large volume spacer, on a microgram equivalent basis in asthmatic children. METHODS: Ten stable asthmatic children of mean age 11 years and forced expiratory volume in one second (FEV1) 81.6% predicted, who were re